TY - JOUR
T1 - Group-I metabotropic glutamate receptors, mGlu1a and mGlu5a, couple to extracellular signal-regulated kinase (ERK) activation via distinct, but overlapping, signalling pathways
AU - Thandi, Sukhwinder
AU - Blank, Jonathan L
AU - Challiss, R A John
PY - 2002/12
Y1 - 2002/12
N2 - The coupling of the group I metabotropic glutamate receptors, mGlu1a and mGlu5a, to the extracellular signal-regulated protein kinase (ERK) pathway has been studied in Chinese hamster ovary cell-lines where receptor expression is under inducible control. Both mGlu receptors stimulated comparable, robust and agonist concentration-dependent ERK activations in the CHO cell-lines. The mGlu1a receptor-mediated ERK response was almost completely attenuated by pertussis toxin (PTx) pretreatment, whereas the mGlu5a-ERK response, and the phosphoinositide response to activation of either receptor, was PTx-insensitive. mGlu1a and mGlu5a receptor coupling to ERK occurred via mechanisms independent of phosphoinositide 3-kinase activity and intracellular and/or extracellular Ca2+ concentration. While acute treatment with a protein kinase C (PKC) inhibitor did not attenuate agonist-stimulated ERK activation, down-regulation of PKCs by phorbol ester treatment for 24 h did attenuate both mGlu1a and mGlu5a receptor-mediated responses. Further, inhibition of Src non-receptor tyrosine kinase activity by PP1 attenuated the ERK response generated by both receptor subtypes, but only mGlu1a receptor-ERK activation was attenuated by PDGF receptor tyrosine kinase inhibitor AG1296. These findings demonstrate that, although expressed in a common cell background, these closely related mGlu receptors utilize different G proteins to cause ERK activation and may recruit different tyrosine kinases to facilitate this response.
AB - The coupling of the group I metabotropic glutamate receptors, mGlu1a and mGlu5a, to the extracellular signal-regulated protein kinase (ERK) pathway has been studied in Chinese hamster ovary cell-lines where receptor expression is under inducible control. Both mGlu receptors stimulated comparable, robust and agonist concentration-dependent ERK activations in the CHO cell-lines. The mGlu1a receptor-mediated ERK response was almost completely attenuated by pertussis toxin (PTx) pretreatment, whereas the mGlu5a-ERK response, and the phosphoinositide response to activation of either receptor, was PTx-insensitive. mGlu1a and mGlu5a receptor coupling to ERK occurred via mechanisms independent of phosphoinositide 3-kinase activity and intracellular and/or extracellular Ca2+ concentration. While acute treatment with a protein kinase C (PKC) inhibitor did not attenuate agonist-stimulated ERK activation, down-regulation of PKCs by phorbol ester treatment for 24 h did attenuate both mGlu1a and mGlu5a receptor-mediated responses. Further, inhibition of Src non-receptor tyrosine kinase activity by PP1 attenuated the ERK response generated by both receptor subtypes, but only mGlu1a receptor-ERK activation was attenuated by PDGF receptor tyrosine kinase inhibitor AG1296. These findings demonstrate that, although expressed in a common cell background, these closely related mGlu receptors utilize different G proteins to cause ERK activation and may recruit different tyrosine kinases to facilitate this response.
KW - Animals
KW - CHO Cells
KW - Calcium/metabolism
KW - Cricetinae
KW - Enzyme Activation/drug effects
KW - Enzyme Activators/pharmacology
KW - Enzyme Inhibitors/pharmacology
KW - Excitatory Amino Acid Agonists/pharmacology
KW - Female
KW - Humans
KW - Hydrolysis/drug effects
KW - Mitogen-Activated Protein Kinases/drug effects
KW - Ovary/cytology
KW - Pertussis Toxin/pharmacology
KW - Phosphatidylinositols/metabolism
KW - Phosphoinositide-3 Kinase Inhibitors
KW - Protein Kinase C/antagonists & inhibitors
KW - Quisqualic Acid/pharmacology
KW - Receptor, Metabotropic Glutamate 5
KW - Receptors, Metabotropic Glutamate/genetics
KW - Receptors, Platelet-Derived Growth Factor/antagonists & inhibitors
KW - Signal Transduction/drug effects
KW - src-Family Kinases/antagonists & inhibitors
U2 - 10.1046/j.1471-4159.2002.01217.x
DO - 10.1046/j.1471-4159.2002.01217.x
M3 - Article
C2 - 12437585
SN - 0022-3042
VL - 83
SP - 1139
EP - 1153
JO - Journal of Neurochemistry
JF - Journal of Neurochemistry
IS - 5
ER -